Corami Biotech Inc.
PrivateLast Round
Seed Round
Feb 4, 2026
Total Funding Raised
$2.03M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Corami Biotech Inc. operates in Healthcare & Life Sciences and is based in Memphis, Tennessee. Its latest recorded funding round was a Grant round in December 2025.
Corami Biotech Inc. is a biotechnology company developing a platform for targeted cardiac therapeutic delivery and placement to treat heart disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Corami Biotech Inc. Comparables
Compare Corami Biotech Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SmartCella Holding AB | 73% | |
| BioCardia Inc | 68% | |
| AtriCure Inc | 59% |
For institutional investors. Book with your work email.
Corami Biotech Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed Round | Feb 4, 2026 | ||||
| Grant | Dec 9, 2025 | ||||
| Grant | Aug 18, 2025 | ||||
| Angel | Oct 24, 2024 | ||||
| Accelerator | Sep 24, 2024 | ||||
Grant | Sep 23, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Corami Biotech Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| U.S. Department of Health and Human Services | Grant |
| NIH RADx | Grant |
| Georgia Research Alliance | Grant |
| ZeroTo510 | Accelerator |
| Tennessee Technology Development Corporation | Grant, Angel |
| Epicenter | Accelerator |
| National Heart, Lung, and Blood Institute | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 59% MoM.
- Jul 26, 2026
Monthly visitors grew 103% MoM, reaching 1K.
For institutional investors. Book with your work email.
Corami Biotech Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Corami Biotech Inc.'s valuation, stock price, and market status.
Is Corami Biotech Inc. a public or private company?
Corami Biotech Inc. is a private company.
What is the current stock price of Corami Biotech Inc.?
Corami Biotech Inc. is a private company, so its shares have no public market price. Caplight tracks Corami Biotech Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Corami Biotech Inc. worth (valuation)?
Valuation information for Corami Biotech Inc. is not publicly available.
Can I buy Corami Biotech Inc. stock?
Corami Biotech Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Corami Biotech Inc.'s last funding round?
Corami Biotech Inc.'s most recent funding round was Seed Round on February 4, 2026.
Who are the main investors in Corami Biotech Inc.?
Key investors in Corami Biotech Inc. include Tennessee Technology Development Corporation, National Heart, Lung, and Blood Institute.
Will Corami Biotech Inc. IPO soon?
No public IPO plans have been announced for Corami Biotech Inc..
How can I track Corami Biotech Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Corami Biotech Inc.'s shares on secondary markets.